Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation
source: pixabay.com

Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation

According to a story from BioSpace, the gene therapy company Axovant Gene Therapies Ltd. recently announced that it has been given Rare Pediatric Disease designation from the US Food and…

Continue Reading Experimental Gene Therapy for GM1 Gangliosidosis Earns Rare Pediatric Disease Designation
Close Menu